Class II Phosphoinositide 3-Kinases as Novel Drug Targets-Reference-Cited by-同舟云学术

Class II Phosphoinositide 3-Kinases as Novel Drug Targets

Published:2016-10-21 Issue:1 Volume:60 Page:47-65
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Falasca Marco¹,Hamilton Justin R.²,Selvadurai Maria²,Sundaram Krithika³,Adamska Aleksandra¹,Thompson Philip E.³

Affiliation:

1. Metabolic Signalling Group, School of Biomedical Sciences, CHIRI Biosciences, Curtin University, Perth, Western Australia 6845, Australia

2. Australian Centre for Blood Diseases and Department of Clinical Haematology, Monash University, 99 Commercial Road, Melbourne, Victoria 3004, Australia

3. Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00963

Reference159 articles.

1. The Phosphoinositide 3-Kinase Pathway

2. Classes of phosphoinositide 3-kinases at a glance

3. Signalling through Class I PI3Ks in mammalian cells

4. PI3K signalling: the path to discovery and understanding

5. Signaling by the Phosphoinositide 3-Kinase Family in Immune Cells

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-03

2. Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions;Molecular Cancer;2024-08-10

3. Targeted small molecule therapy and inhibitors for lymphoma;Future Medicinal Chemistry;2024-07-17

4. Discoidin domain receptor 2 signaling through PIK3C2α in fibroblasts promotes lung fibrosis;The Journal of Pathology;2024-02-09

5. Identification of Prognostic Markers and Potential Therapeutic Targets using Gene Expression Profiling and Simulation Studies in Pancreatic Cancer;Current Computer-Aided Drug Design;2023-12